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Purpose: Sulforaphane (SFN) is an isothiocyanate (ITC) obtained from
the diet, and is particularly abundant after consumption of the mus-
tard family of Brassicaceae. ITCs are purported to have many health
beneﬁts and SFN has been shown to prevent cartilage degradation in
laboratory models of osteoarthritis. This study examined whether ITCs
obtained from the diet could impact on tissues of the human synovial
joint.
Methods: Forty patients scheduled for total knee replacement due to
osteoarthritis were recruited to the Norwich Broccoli and Osteoarthritis
Study (NBOS). Following a washout period (a low ITC diet), the patients
were randomly allocated to continue the low ITC diet or to consume
100g of high glucosinolate broccoli for a further 2 weeks. Tissue levels of
ITCs were measured by cyclocondensation reaction and HPLC. In vitro
rates of cartilage degradation were assessed. Plasma was analysed for
lipids, the Coll2-1 degradation marker and hsCRP levels. Cytokine
expression was measured by FACS analysis and gene expression was
measured by RT-qPCR. Data were analysed for the effect of glutathione
transferase (GST) genotype.
Results: ITCs were detected in plasma and synovial ﬂuid (SF) and
these were signiﬁcantly higher in the broccoli groups compared to
control (plasma control 0.89mM±0.45 vs broccoli 2.19mM±1.42,
p<0.0001). ITCs were not detected in SF from the control group. Mean
total ITC levels in SF measured in the broccoli group were
496.nM±140. Plasma triglycerides were signiﬁcantly decreased within
the broccoli group at post-intervention compared to washout
(p¼0.0046) but were not signiﬁcantly different in the broccoli group
compared to control. No signiﬁcant differences were seen between
groups for SF cytokine protein expression or in vitro cartilage degra-
dation experiments.
Conclusions: The high glucosinolate broccoli diet was well tolerated.
ITCs obtained from the diet can be detected in the tissues of the synovial
joint. A short term high glucosinolate diet was not sufﬁcient to impact
on the rate of cartilage destruction in vitro. Studies of gene expression in
cartilage and infrapatellar fat pad tissues are ongoing.
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THE EFFECT OF COLLAGEN HYDROLYSATES ON THE ACTIVITY OF
AGGRECANASES AND THE RELEASE OF PROTEOGLYCANS FROM
HUMAN OSTEOARTHRITIC ARTICULAR CARTILAGE
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Purpose: The aggrecanases ADAMTS4 (a disintegrin and metal-
loproteinase with a thrombospondin motif) and ADAMTS5 play a
central role in the proteolytic degradation of osteoarthritic articular
cartilage. Collagen hydrolysate (CH), consisting of type I collagen
peptides are often used as dietary supplements for osteoarthritis. Our
in silico calculations have revealed that the different collagen type I
peptides bind to various docking sites on the aggrecanases so that
their activities are affected differently. We also showed that small
collagen peptides bind weakly to the a2A-domain of the integrin
receptor, and that this represents another possible mechanism of
action [Siebert et al. 2010 St€otzel et al. 2012]. Interestingly, our studieswith CHs of bovine origin revealed considerable differences in their
molecular composition and their effects on human chondrocytes
[Schadow et al. 2013].
The aim of this study was to test the extent to which two commercially
available CHs are able ﬁrstly to inﬂuence the activity of ADAMTS4 and
ADAMTS5 in vitro, and secondly to modulate the release of proteogly-
cans from human osteoarthritic cartilage explants.
Methods: The differing composition of the CHs from hydrolytically
generated collagen peptides was determined by MALDI-TOF mass
spectrometry (MS). The activity of rhADAMTS4 and rhADAMTS5 was
determined in the presence of the two CHs (Peptan™ F 5000 HD
from Rousselot, and Mobiforte® from Astrid Twardy) using rhAg-
grecan-IGD as substrate, whereby the proteolytically released
aggrecan peptide with the N-terminal sequence ARGSVIL was
quantiﬁed in a microtitre plate using a mAb assay. The cartilage
explants from the lateral condyle of the femur were obtained during
a knee TEP implantation after written consent was obtained from the
patients subsequent to approval by the local university ethics com-
mittee. After macroscopic evaluation of the arthritic changes using
Collins’ procedure, explants were then prepared and cultivated. The
extent of cartilage degradation was determined using explants after a
6 day treatment with 0-10 mg/ml CH where medium was changed
after 3 days. Proteoglycan content was measured using the DMMB
method, with TIMP-3 and MMP-3 content being determined by ELISA
and NO content being measured using the Griess reaction. The
vitality of the explants was determined by ﬂuorescence microscopy.
The results were compared with untreated control samples. Each
experiment was repeated ﬁve times (n ¼ 6). The data was statisti-
cally analysed by ANOVA analysis.
Results: MALDI-TOF MS revealed striking differences between the
different preparations. They differed both in terms of the composition
of their mixtures regarding individual peptide CH fragments, and in
terms of their mean molecular weight. For Peptan™ F 5000 HD the
mean molecular weight was 3,600 Da, while for Mobiforte® it was
slightly smaller at 3,300 Da. Only Mobiforte® signiﬁcantly and con-
centration-dependently stimulated the activity of rhADAMTS4 and
rhADAMTS5. This probably allosterically-induced stimulation was
associated with a signiﬁcantly increased release of proteoglycans and
NO from human cartilage explants, while no effect was measured with
respect to TIMP-3 levels. Peptan F™ 5000 HD concentration-depend-
ently inhibited the activity of aggrecanases, while no effect was
measured for the NO concentrations, proteoglycan release or the levels
of TIMP-3.
Conclusions: The CHs differ signiﬁcantly regarding the molecular
composition of the peptide mixtures, and also regarding their catabolic
effects on human osteoarthritic articular cartilage. Before their use in
patients, CHs should be thoroughly investigated regarding their effects
ﬁrst in vitro and then in vivo before being declared as safe and
effective.OA: Outcomes
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DEVELOPMENT AND TESTING OF A COMPUTERIZED ANIMATED
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